Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAPR Capricor Therapeutics Inc

未开盘 07-08 16:00:00 EDT

10.17

+0.27

+2.73%

盘后10.22

+0.05+0.49%

19:59 EDT

最高10.30	最低9.87	成交量98.96万
今开9.98	昨收9.90	日振幅4.34%
总市值4.65亿	流通市值4.09亿	总股本4,571万
成交额998.51万	换手率2.46%	流通股本4,018万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":10.17,"timestamp":1752004800000,"preClose":9.9,"halted":0,"volume":989637,"hourTrading":{"tag":"盘后","latestPrice":10.22,"preClose":10.17,"latestTime":"19:59 EDT","volume":236237,"amount":2402485.6963,"timestamp":1752019179471},"delay":0,"floatShares":40176277,"shares":45707819,"eps":-1.419591,"marketStatus":"未开盘","change":0.27,"latestTime":"07-08 16:00:00 EDT","open":9.98,"high":10.2999,"low":9.87,"amount":9985136.480352,"amplitude":0.043424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.419591,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752048000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.9,"preHourTrading":{"tag":"盘前","latestPrice":9.98,"preClose":9.9,"latestTime":"09:28 EDT","volume":3039,"amount":30090.99279,"timestamp":1751981282076},"postHourTrading":{"tag":"盘后","latestPrice":10.22,"preClose":10.17,"latestTime":"19:59 EDT","volume":236237,"amount":2402485.6963,"timestamp":1752019179471},"volumeRatio":0.791635,"impliedVol":2.1102,"impliedVolPercentile":0.8715},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"2546758665","title":"Capricor Therapeutics(CAPR.US)获B. Riley Securities首次覆盖，给予买入评级, 目标价21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546758665","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546758665?lang=zh_cn&edition=full","pubTime":"2025-06-27 00:32","pubTimestamp":1750955527,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics(CAPR.US)获B. Riley Securities首次覆盖，给予买入评级, 目标价21.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/27003251332448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2546588287","title":"Capricor Therapeutics(CAPR.US)获B. Riley Securities首次覆盖，给予买入评","url":"https://stock-news.laohu8.com/highlight/detail?id=2546588287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546588287?lang=zh_cn&edition=full","pubTime":"2025-06-27 00:21","pubTimestamp":1750954915,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","CAPR","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2546210576","title":"Jones Trading：维持Capricor Therapeutics评级，由买入调整至买入评级, 目标价由40.00美元调整至29.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546210576","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546210576?lang=zh_cn&edition=full","pubTime":"2025-06-25 20:14","pubTimestamp":1750853685,"startTime":"0","endTime":"0","summary":"Jones Trading：维持Capricor Therapeutics(CAPR.US)评级，由买入调整至买入评级, 目标价由40.00美元调整至29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625201703978e6ab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625201703978e6ab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2546217443","title":"Jones Trading：维持Capricor Therapeutics(CAPR.US)评级，由买入调整至买入评级,","url":"https://stock-news.laohu8.com/highlight/detail?id=2546217443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546217443?lang=zh_cn&edition=full","pubTime":"2025-06-25 20:09","pubTimestamp":1750853376,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4539","CAPR","BK4139","BK4007"],"gpt_icon":0},{"id":"2545844963","title":"奥本海默：维持Capricor Therapeutics(CAPR.US)评级，由优于大市调整至优于大市评级, 目标价由43.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545844963","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545844963?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:45","pubTimestamp":1750697101,"startTime":"0","endTime":"0","summary":"奥本海默：维持Capricor Therapeutics(CAPR.US)评级，由优于大市调整至优于大市评级, 目标价由43.00美元调整至22.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/24004551249573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2545446094","title":"奥本海默：维持Capricor Therapeutics(CAPR.US)评级，由优于大市调整至优于大市评级, 目标价由","url":"https://stock-news.laohu8.com/highlight/detail?id=2545446094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545446094?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:30","pubTimestamp":1750696225,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4139","CAPR","LENZ","BK4539"],"gpt_icon":0},{"id":"2545921486","title":"【财闻联播】深圳一俱乐部会籍，起拍价1100万元！华科大获1.8亿元个人匿名捐款","url":"https://stock-news.laohu8.com/highlight/detail?id=2545921486","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545921486?lang=zh_cn&edition=full","pubTime":"2025-06-21 20:25","pubTimestamp":1750508700,"startTime":"0","endTime":"0","summary":"华科大获1.8亿元个人匿名捐款华中科技大学消息，6月21日，华中科技大学获捐一笔1.8亿元人民币的个人匿名善款。据了解，这是华中科技大学有史以来单笔最大捐赠。据悉，这项初步禁令保留了哈佛大学在案件审理期间接收国际学生的权利。公告提及，竞买人应为余杭区或临平区企业。★公司动态★深圳一俱乐部会籍将被拍卖，起拍价1100万元阿里拍卖平台显示，深圳一俱乐部会籍将于7月14日开始拍卖，起拍价1100万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-06-21/doc-infavyqy4905955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","LU0302445910.USD","LU1201861249.SGD","CAPR","LU0648001328.SGD","KR","BK4585","LU0130102774.USD","BK4588","LU0345770308.USD","LU0477156953.USD","BK4533","LU0312595415.SGD","BK4559","LU0980610538.SGD","BK4504","LU2275660780.HKD","BK4532","LU0130517989.USD","BK4113","LU0345770993.USD"],"gpt_icon":0},{"id":"2545017235","title":"生物科技公司Capricor Therapeutics恢复交易跌幅达46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545017235","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545017235?lang=zh_cn&edition=full","pubTime":"2025-06-21 01:43","pubTimestamp":1750441382,"startTime":"0","endTime":"0","summary":"6月21日，生物科技公司Capricor Therapeutics Inc.（CAPR）股票恢复交易后，跌幅扩大至46%。此情况或与市场对其业务前景及财务状况的评估有关，具体原因尚待进一步披露。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210145149525057d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506210145149525057d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2545174998","title":"生物科技公司Capricor Therapeutics Inc.（CAPR）恢复交易跌幅扩大至46%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2545174998","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545174998?lang=zh_cn&edition=full","pubTime":"2025-06-21 01:23","pubTimestamp":1750440220,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CAPR","BK4539","LENZ","BK4007","BK4139","159837"],"gpt_icon":0},{"id":"2536653636","title":"Capricor Therapeutics, Inc.2025财年第一财季实现净利润-24.39百万美元，同比减少149.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536653636","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536653636?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:00","pubTimestamp":1747670426,"startTime":"0","endTime":"0","summary":"5月20日，Capricor Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-24.39百万美元，同比减少149.13%；其中营业收入为0.00美元，每股基本收益为-0.53美元。机构评级：截至2025年5月20日，当前有7家机构对Capricor Therapeutics, Inc.目标价做出预测，其中目标均价为43.71美元，其中最低目标价为25.00美元，最高目标价为77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000034a6e4efce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000034a6e4efce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ"],"gpt_icon":0},{"id":"2536412033","title":"Capricor Therapeutics, Inc.盘中异动 下午盘大幅跳水5.12%报9.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536412033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536412033?lang=zh_cn&edition=full","pubTime":"2025-05-17 02:42","pubTimestamp":1747420935,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日02时42分，Capricor Therapeutics, Inc.股票出现波动，股价急速下跌5.12%。截至发稿，该股报9.07美元/股，成交量246.82万股，换手率5.40%，振幅8.94%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。该公司的产品线包括 CAP-1002、deramiocel，一种异体心脏衍生细胞疗法。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024215a6e1fa1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517024215a6e1fa1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2535076592","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速拉升8.22%报7.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535076592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535076592?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:30","pubTimestamp":1747229423,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时30分，Capricor Therapeutics, Inc.股票出现异动，股价大幅拉升8.22%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Septerna, Inc.、蓝鸟生物、Absci Corporation涨幅较大，Nucana Plc、Quoin Pharmaceuticals Ltd、Polyrizon Ltd.较为活跃，换手率分别为1656.07%、1153.65%、1001.18%，振幅较大的相关个股有Trevi Therapeutics, Inc.、Affimed N.V.、Sangamo Therapeutics, Inc.，振幅分别为4.49%、3.88%、3.61%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213024aa2c8e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213024aa2c8e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CAPR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2533931220","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.07%报6.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533931220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533931220?lang=zh_cn&edition=full","pubTime":"2025-05-07 22:00","pubTimestamp":1746626404,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日22时00分，Capricor Therapeutics, Inc.股票出现波动，股价急速下挫5.07%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507220004a475750c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507220004a475750c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2533587318","title":"Capricor Therapeutics, Inc.盘中异动 快速跳水5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533587318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533587318?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:31","pubTimestamp":1746451868,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时31分，Capricor Therapeutics, Inc.股票出现波动，股价急速下挫5.73%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213108a472d73a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213108a472d73a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","CAPR"],"gpt_icon":0},{"id":"2530165619","title":"Capricor Therapeutics, Inc.盘中异动 下午盘大幅下跌5.12%报12.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530165619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530165619?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:54","pubTimestamp":1745603686,"startTime":"0","endTime":"0","summary":"北京时间2025年04月26日01时54分，Capricor Therapeutics, Inc.股票出现异动，股价急速跳水5.12%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042601544694e2c8b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042601544694e2c8b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ","BK4007"],"gpt_icon":0},{"id":"2528380743","title":"Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528380743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528380743?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:31","pubTimestamp":1744896666,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时31分，Capricor Therapeutics, Inc.股票出现波动，股价急速拉升5.81%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、Portage Biotech Inc.涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为345.88%、129.32%、43.56%，振幅较大的相关个股有Channel Therapeutics Corporation、Celularity Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为17.53%、11.59%、9.60%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213106a6be09b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213106a6be09b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2527448364","title":"Capricor Therapeutics, Inc.盘中异动 早盘急速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527448364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527448364?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:01","pubTimestamp":1744725670,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时01分，Capricor Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Mural Oncology Plc、Skye Bioscience, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Mural Oncology Plc、Metavia Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为669.30%、219.88%、87.91%，振幅较大的相关个股有Skye Bioscience, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Mural Oncology Plc，振幅分别为171.53%、80.08%、66.02%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041522011094d63260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041522011094d63260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2518279724","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.15%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518279724?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Capricor Therapeutics, Inc.股票出现波动，股价急速下跌5.15%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2516378816","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516378816?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:52","pubTimestamp":1741013572,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时52分，Capricor Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为687.54%、115.08%、86.65%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、40.78%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139"],"gpt_icon":0},{"id":"2514967857","title":"Capricor Therapeutics, Inc.盘中异动 快速下跌5.00%报15.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514967857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514967857?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:52","pubTimestamp":1740585161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时52分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5442.90%、206.70%、195.43%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":0.0485},{"period":"1month","weight":-0.2853},{"period":"3month","weight":0.0819},{"period":"6month","weight":-0.2662},{"period":"1year","weight":1.1321},{"period":"ytd","weight":-0.263}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的疗法，用于治疗Duchenne肌营养不良症（“DMD”），这是一种罕见的导致肌肉退化和过早死亡的肌营养不良症，以及具有高度未满足的医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.163345},{"month":2,"riseRate":0.5,"avgChangeRate":-0.013804},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020487},{"month":4,"riseRate":0.454545,"avgChangeRate":0.454133},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.152616},{"month":6,"riseRate":0.636364,"avgChangeRate":0.035159},{"month":7,"riseRate":0.454545,"avgChangeRate":0.092939},{"month":8,"riseRate":0.6,"avgChangeRate":0.032614},{"month":9,"riseRate":0.4,"avgChangeRate":0.368975},{"month":10,"riseRate":0.1,"avgChangeRate":-0.099537},{"month":11,"riseRate":0.4,"avgChangeRate":-0.086131},{"month":12,"riseRate":0.1,"avgChangeRate":-0.130786}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}